Larvol Delta - Arch-Biopartners-Announces-Dosing-of-First-Patient-in-Turkey-in-Phase-II-Trial-of-LSALT-peptide-to-Treat-Complications-from-Covid19

MetaBlok (lsalt peptide) - Arch Biopartners

http://www.globenewswire.com/news-release/2020/11/05/2121049/0/en/Arch-Biopartners-Announces-Dosing-of-First-Patient-in-Turkey-in-Phase-II-Trial-of-LSALT-peptide-to-Treat-Complications-from-Covid-19.html

Nov 5, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next